Concepts (211)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antitubercular Agents | 10 | 2018 | 54 | 1.700 |
Why?
|
| Appendicitis | 2 | 2020 | 66 | 1.340 |
Why?
|
| Extensively Drug-Resistant Tuberculosis | 7 | 2017 | 7 | 1.230 |
Why?
|
| Colon | 3 | 2018 | 521 | 1.210 |
Why?
|
| Diverticulitis, Colonic | 2 | 2018 | 11 | 1.090 |
Why?
|
| Tuberculosis, Multidrug-Resistant | 9 | 2018 | 12 | 1.030 |
Why?
|
| Laparoscopy | 4 | 2019 | 780 | 0.820 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2014 | 244 | 0.800 |
Why?
|
| Intubation, Gastrointestinal | 1 | 2019 | 31 | 0.660 |
Why?
|
| Gastrostomy | 1 | 2019 | 70 | 0.640 |
Why?
|
| Postoperative Complications | 4 | 2020 | 2314 | 0.600 |
Why?
|
| Hospital Charges | 1 | 2018 | 29 | 0.600 |
Why?
|
| Hospitals, Pediatric | 2 | 2019 | 117 | 0.590 |
Why?
|
| Feces | 1 | 2018 | 333 | 0.520 |
Why?
|
| Knowledge | 1 | 2015 | 28 | 0.510 |
Why?
|
| Diverticulosis, Colonic | 1 | 2015 | 2 | 0.500 |
Why?
|
| Surgical Procedures, Operative | 1 | 2018 | 206 | 0.500 |
Why?
|
| New York | 5 | 2021 | 73 | 0.490 |
Why?
|
| Diverticulitis | 1 | 2014 | 10 | 0.490 |
Why?
|
| Tuberculosis, Pulmonary | 4 | 2018 | 58 | 0.480 |
Why?
|
| Dietary Supplements | 1 | 2015 | 124 | 0.480 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2014 | 33 | 0.480 |
Why?
|
| Diverticulum, Colon | 1 | 2014 | 10 | 0.470 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2016 | 128 | 0.470 |
Why?
|
| HIV Infections | 5 | 2013 | 846 | 0.470 |
Why?
|
| Probiotics | 1 | 2015 | 89 | 0.470 |
Why?
|
| Length of Stay | 1 | 2018 | 749 | 0.460 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2014 | 46 | 0.460 |
Why?
|
| Intestinal Perforation | 1 | 2014 | 36 | 0.460 |
Why?
|
| Pneumonia | 1 | 2016 | 183 | 0.460 |
Why?
|
| Intestinal Diseases | 1 | 2014 | 79 | 0.460 |
Why?
|
| Gastrointestinal Diseases | 1 | 2015 | 151 | 0.450 |
Why?
|
| Veterans Health | 1 | 2013 | 16 | 0.450 |
Why?
|
| Bacteria | 1 | 2018 | 486 | 0.440 |
Why?
|
| Mycobacterium tuberculosis | 6 | 2017 | 197 | 0.440 |
Why?
|
| Child | 9 | 2021 | 7240 | 0.390 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2014 | 239 | 0.380 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2015 | 594 | 0.380 |
Why?
|
| Surgeons | 1 | 2015 | 249 | 0.370 |
Why?
|
| Male | 25 | 2024 | 42674 | 0.370 |
Why?
|
| Humans | 37 | 2024 | 89961 | 0.370 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2018 | 520 | 0.360 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 4 | 2015 | 52 | 0.360 |
Why?
|
| Female | 25 | 2024 | 46587 | 0.350 |
Why?
|
| Retrospective Studies | 13 | 2021 | 9210 | 0.350 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2010 | 33 | 0.350 |
Why?
|
| Mammography | 1 | 2013 | 475 | 0.350 |
Why?
|
| Risk Factors | 9 | 2021 | 5558 | 0.340 |
Why?
|
| Early Detection of Cancer | 1 | 2013 | 422 | 0.330 |
Why?
|
| Obesity | 1 | 2016 | 972 | 0.320 |
Why?
|
| Logistic Models | 4 | 2020 | 1214 | 0.300 |
Why?
|
| Colorectal Neoplasms | 1 | 2016 | 980 | 0.300 |
Why?
|
| Middle Aged | 17 | 2021 | 26146 | 0.280 |
Why?
|
| Child, Preschool | 5 | 2020 | 3771 | 0.260 |
Why?
|
| South Africa | 5 | 2017 | 60 | 0.260 |
Why?
|
| Infant | 4 | 2024 | 3188 | 0.250 |
Why?
|
| Pediatrics | 2 | 2021 | 360 | 0.250 |
Why?
|
| Herniorrhaphy | 2 | 2024 | 91 | 0.250 |
Why?
|
| Pandemics | 2 | 2021 | 778 | 0.240 |
Why?
|
| Aged | 12 | 2021 | 19254 | 0.240 |
Why?
|
| Colitis, Ulcerative | 3 | 2020 | 760 | 0.230 |
Why?
|
| Cohort Studies | 5 | 2021 | 2886 | 0.230 |
Why?
|
| Sputum | 4 | 2015 | 35 | 0.220 |
Why?
|
| Hernia, Inguinal | 1 | 2024 | 75 | 0.210 |
Why?
|
| Adolescent | 11 | 2020 | 9340 | 0.200 |
Why?
|
| Microbial Sensitivity Tests | 5 | 2015 | 151 | 0.200 |
Why?
|
| Infant, Premature | 1 | 2024 | 299 | 0.190 |
Why?
|
| Adult | 15 | 2021 | 26816 | 0.190 |
Why?
|
| Acute-On-Chronic Liver Failure | 1 | 2021 | 4 | 0.190 |
Why?
|
| Hospitalization | 3 | 2020 | 888 | 0.190 |
Why?
|
| Multivariate Analysis | 2 | 2016 | 983 | 0.180 |
Why?
|
| Emergency Shelter | 1 | 2020 | 2 | 0.180 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2021 | 52 | 0.180 |
Why?
|
| Troponin | 1 | 2020 | 24 | 0.180 |
Why?
|
| Ileostomy | 1 | 2020 | 29 | 0.180 |
Why?
|
| Trauma Centers | 1 | 2021 | 148 | 0.180 |
Why?
|
| Appendectomy | 1 | 2020 | 39 | 0.170 |
Why?
|
| Social Determinants of Health | 1 | 2021 | 103 | 0.170 |
Why?
|
| Breast Neoplasms | 1 | 2013 | 3022 | 0.170 |
Why?
|
| Liver Diseases | 1 | 2021 | 242 | 0.170 |
Why?
|
| Aged, 80 and over | 4 | 2021 | 6783 | 0.170 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 1 | 2021 | 93 | 0.170 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2019 | 23 | 0.160 |
Why?
|
| Young Adult | 10 | 2020 | 6409 | 0.160 |
Why?
|
| Colectomy | 1 | 2020 | 175 | 0.160 |
Why?
|
| Enteral Nutrition | 1 | 2019 | 105 | 0.160 |
Why?
|
| Health Status Disparities | 1 | 2021 | 191 | 0.160 |
Why?
|
| Patient Care Team | 1 | 2021 | 284 | 0.160 |
Why?
|
| Prognosis | 2 | 2018 | 3798 | 0.160 |
Why?
|
| Proctocolectomy, Restorative | 1 | 2019 | 105 | 0.150 |
Why?
|
| Health Personnel | 2 | 2010 | 214 | 0.150 |
Why?
|
| Maryland | 1 | 2018 | 44 | 0.150 |
Why?
|
| Ribotyping | 1 | 2018 | 11 | 0.150 |
Why?
|
| Wounds and Injuries | 1 | 2021 | 264 | 0.150 |
Why?
|
| Specialization | 1 | 2018 | 70 | 0.150 |
Why?
|
| Hospitals | 1 | 2020 | 303 | 0.140 |
Why?
|
| Competency-Based Education | 1 | 2017 | 38 | 0.140 |
Why?
|
| Emergencies | 1 | 2018 | 122 | 0.140 |
Why?
|
| Treatment Outcome | 6 | 2019 | 8273 | 0.140 |
Why?
|
| Cost of Illness | 1 | 2018 | 149 | 0.140 |
Why?
|
| Prospective Studies | 5 | 2016 | 4329 | 0.140 |
Why?
|
| Pain, Postoperative | 1 | 2019 | 256 | 0.140 |
Why?
|
| Functional Laterality | 1 | 2017 | 199 | 0.140 |
Why?
|
| Abdominal Pain | 1 | 2018 | 142 | 0.140 |
Why?
|
| Colonoscopy | 2 | 2015 | 281 | 0.130 |
Why?
|
| Infant, Newborn | 2 | 2024 | 2497 | 0.130 |
Why?
|
| Age Factors | 2 | 2024 | 1880 | 0.130 |
Why?
|
| Pain Measurement | 1 | 2018 | 332 | 0.130 |
Why?
|
| Global Health | 2 | 2015 | 193 | 0.130 |
Why?
|
| Healthcare Disparities | 1 | 2021 | 432 | 0.130 |
Why?
|
| Mycobacterium | 1 | 2015 | 18 | 0.130 |
Why?
|
| Recurrence | 2 | 2018 | 1145 | 0.130 |
Why?
|
| Four-Dimensional Computed Tomography | 1 | 2015 | 19 | 0.120 |
Why?
|
| Colorectal Surgery | 1 | 2015 | 22 | 0.120 |
Why?
|
| Medical Audit | 1 | 2015 | 39 | 0.120 |
Why?
|
| Cost-Benefit Analysis | 1 | 2018 | 467 | 0.120 |
Why?
|
| Cholangitis, Sclerosing | 1 | 2015 | 51 | 0.120 |
Why?
|
| Pilot Projects | 1 | 2018 | 872 | 0.120 |
Why?
|
| Celecoxib | 1 | 2014 | 31 | 0.120 |
Why?
|
| Sulfones | 1 | 2014 | 45 | 0.120 |
Why?
|
| Analgesics, Opioid | 1 | 2019 | 451 | 0.120 |
Why?
|
| Observational Studies as Topic | 1 | 2014 | 50 | 0.120 |
Why?
|
| Cyclooxygenase 2 | 1 | 2014 | 99 | 0.120 |
Why?
|
| Models, Theoretical | 1 | 2017 | 493 | 0.120 |
Why?
|
| Hospital Mortality | 3 | 2021 | 408 | 0.120 |
Why?
|
| Databases, Factual | 1 | 2018 | 866 | 0.110 |
Why?
|
| Hospitals, Veterans | 1 | 2013 | 21 | 0.110 |
Why?
|
| Morbidity | 1 | 2014 | 149 | 0.110 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2019 | 608 | 0.110 |
Why?
|
| Surgical Wound Infection | 1 | 2016 | 202 | 0.110 |
Why?
|
| Perioperative Care | 1 | 2015 | 171 | 0.110 |
Why?
|
| Pyrazoles | 1 | 2014 | 150 | 0.110 |
Why?
|
| Education, Medical, Graduate | 1 | 2017 | 402 | 0.110 |
Why?
|
| Feasibility Studies | 1 | 2015 | 785 | 0.100 |
Why?
|
| Coinfection | 1 | 2013 | 62 | 0.100 |
Why?
|
| Gastrointestinal Tract | 1 | 2014 | 192 | 0.100 |
Why?
|
| Pyridines | 1 | 2014 | 300 | 0.100 |
Why?
|
| Ultrasonography | 1 | 2015 | 720 | 0.100 |
Why?
|
| Sulfonamides | 1 | 2014 | 319 | 0.100 |
Why?
|
| Referral and Consultation | 1 | 2015 | 345 | 0.100 |
Why?
|
| Comorbidity | 1 | 2016 | 953 | 0.100 |
Why?
|
| Pain | 1 | 2014 | 399 | 0.100 |
Why?
|
| Survival Rate | 2 | 2020 | 1899 | 0.100 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 1862 | 0.100 |
Why?
|
| Chronic Disease | 1 | 2015 | 958 | 0.100 |
Why?
|
| Clinical Competence | 1 | 2017 | 796 | 0.100 |
Why?
|
| Mastectomy | 1 | 2013 | 246 | 0.090 |
Why?
|
| Neoplasm Staging | 1 | 2016 | 2000 | 0.090 |
Why?
|
| Microbiota | 1 | 2015 | 407 | 0.090 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2010 | 73 | 0.080 |
Why?
|
| Drug Therapy, Combination | 3 | 2018 | 785 | 0.080 |
Why?
|
| Time Factors | 2 | 2021 | 5358 | 0.080 |
Why?
|
| Clinical Trials as Topic | 1 | 2014 | 1134 | 0.080 |
Why?
|
| Cross Infection | 1 | 2010 | 151 | 0.080 |
Why?
|
| Mass Screening | 1 | 2013 | 647 | 0.080 |
Why?
|
| Internship and Residency | 1 | 2017 | 1062 | 0.070 |
Why?
|
| Gestational Age | 1 | 2024 | 329 | 0.050 |
Why?
|
| Incidence | 2 | 2021 | 1603 | 0.050 |
Why?
|
| Bayes Theorem | 1 | 2024 | 382 | 0.050 |
Why?
|
| Liver Function Tests | 1 | 2021 | 92 | 0.050 |
Why?
|
| New York City | 1 | 2021 | 61 | 0.050 |
Why?
|
| Patient Discharge | 1 | 2024 | 326 | 0.050 |
Why?
|
| Population Density | 1 | 2021 | 61 | 0.050 |
Why?
|
| Renal Insufficiency | 1 | 2021 | 97 | 0.040 |
Why?
|
| Educational Status | 1 | 2021 | 195 | 0.040 |
Why?
|
| Orchiopexy | 1 | 2019 | 2 | 0.040 |
Why?
|
| Testicular Hydrocele | 1 | 2019 | 4 | 0.040 |
Why?
|
| Poverty | 1 | 2021 | 183 | 0.040 |
Why?
|
| Residence Characteristics | 1 | 2021 | 203 | 0.040 |
Why?
|
| Liver Cirrhosis | 1 | 2021 | 257 | 0.040 |
Why?
|
| Respiratory Insufficiency | 1 | 2021 | 162 | 0.040 |
Why?
|
| United States | 2 | 2024 | 7108 | 0.040 |
Why?
|
| Capreomycin | 1 | 2018 | 1 | 0.040 |
Why?
|
| Clofazimine | 1 | 2018 | 1 | 0.040 |
Why?
|
| Diarylquinolines | 1 | 2018 | 1 | 0.040 |
Why?
|
| Kanamycin | 1 | 2018 | 4 | 0.040 |
Why?
|
| Amikacin | 1 | 2018 | 5 | 0.040 |
Why?
|
| Linezolid | 1 | 2018 | 3 | 0.040 |
Why?
|
| Levofloxacin | 1 | 2018 | 8 | 0.040 |
Why?
|
| Carbapenems | 1 | 2018 | 12 | 0.040 |
Why?
|
| Fluoroquinolones | 1 | 2018 | 22 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2020 | 682 | 0.040 |
Why?
|
| Tertiary Care Centers | 1 | 2019 | 110 | 0.040 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2019 | 74 | 0.040 |
Why?
|
| Treatment Failure | 1 | 2018 | 278 | 0.040 |
Why?
|
| Drug Prescriptions | 1 | 2019 | 141 | 0.040 |
Why?
|
| Russia | 1 | 2017 | 26 | 0.040 |
Why?
|
| Asia | 1 | 2017 | 102 | 0.040 |
Why?
|
| Motor Skills | 1 | 2017 | 79 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 1732 | 0.030 |
Why?
|
| Simulation Training | 1 | 2017 | 100 | 0.030 |
Why?
|
| Leukocyte L1 Antigen Complex | 1 | 2015 | 48 | 0.030 |
Why?
|
| Clinical Protocols | 1 | 2015 | 158 | 0.030 |
Why?
|
| Hypertension | 1 | 2021 | 747 | 0.030 |
Why?
|
| Genotyping Techniques | 1 | 2014 | 69 | 0.030 |
Why?
|
| Biomarkers | 1 | 2020 | 1778 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2015 | 848 | 0.030 |
Why?
|
| Ethionamide | 1 | 2013 | 1 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2021 | 2327 | 0.030 |
Why?
|
| Ethambutol | 1 | 2013 | 6 | 0.030 |
Why?
|
| Pyrazinamide | 1 | 2013 | 5 | 0.030 |
Why?
|
| Cycloserine | 1 | 2013 | 5 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 3678 | 0.030 |
Why?
|
| Biopsy | 1 | 2015 | 1184 | 0.020 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2010 | 32 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2013 | 855 | 0.020 |
Why?
|
| Intestinal Mucosa | 1 | 2015 | 806 | 0.020 |
Why?
|
| Selection, Genetic | 1 | 2014 | 515 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2012 | 596 | 0.020 |
Why?
|
| Crohn Disease | 1 | 2015 | 764 | 0.020 |
Why?
|
| Prevalence | 1 | 2012 | 1250 | 0.020 |
Why?
|